Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Qiming Venture Partners USA, established in January 2017, operates as the first US-based team and fund of the prominent China-based venture capital firm Qiming Venture Partners. The firm is headquartered in Menlo Park, California, with additional offices in Cambridge, Massachusetts, and Seattle, Washington. Qiming Venture Partners USA focuses on early-stage investments in the healthcare sector, particularly in therapeutics and digital health. The firm has successfully raised a total of $550 million across three funds, establishing a diverse portfolio of over 30 companies.
Since its inception, Qiming Venture Partners USA has been actively involved in the healthcare industry, emphasizing disruptive and next-generation therapies. The firm has facilitated 11 mergers and acquisitions (M&A) and initial public offerings (IPOs), showcasing its commitment to fostering innovation in healthcare. The strong connection to the China market allows Qiming to leverage its extensive network, providing portfolio companies with valuable resources and insights to enhance their growth potential.
Qiming Venture Partners USA specializes in early-stage investments, primarily targeting the healthcare sector in North America and Europe. The firm invests across various stages, including pre-seed, seed, seed-plus (extension), and Series A. Their investment strategy emphasizes therapeutics and digital health, seeking to identify and support innovative solutions that can significantly impact the healthcare landscape.
The firm looks for entrepreneurs who are dedicated to developing transformative healthcare solutions. Qiming Venture Partners USA values strong leadership teams and innovative business models that address pressing healthcare challenges. The firm’s investment approach includes providing access to capital, connections, and community resources, which are essential for startups aiming to disrupt the healthcare market.
Qiming Venture Partners USA has built a diverse portfolio of over 30 companies, focusing on healthcare innovation. Notable companies in their portfolio include:
In addition to these companies, Qiming Venture Partners USA has been involved in 11 M&A and IPO transactions, reflecting its active role in the healthcare investment space.
Mark McDade: Managing Partner with extensive experience in venture capital and healthcare investments.
Anna French, D. Phil. (Ph.D.): Managing Partner with a strong background in healthcare innovation and investment strategy.
Gary Rieschel: Managing Partner, known for his expertise in cross-border investments and healthcare technology.
Will McConnell: Principal with a focus on early-stage healthcare companies and market analysis.
Artavazd Arumov, Ph.D.: Principal specializing in therapeutics and digital health investments.
Lauren Duhamel, Ph.D.: Associate with a background in healthcare research and investment.
Franklin Berger: Senior Advisor with extensive experience in healthcare and venture capital.
Geoffrey M. Duyk, MD, Ph.D.: Senior Advisor with a focus on biotechnology and therapeutics.
Sheila Gujrathi, MD: Senior Advisor specializing in clinical development and healthcare strategy.
Rich Murray, Ph.D.: Senior Advisor with expertise in drug development and commercialization.
Robert Headley: Operating Partner with a focus on operational support for portfolio companies.
David Chu: Operating Partner specializing in healthcare investments and market access.
Ryan Baker: Chief Financial Officer overseeing financial operations and strategy.
Laurel Brakus: Executive Assistant & Operations, supporting day-to-day operations.
Holly Schlichting: Executive Assistant & Operations, assisting with administrative functions.
Emma Sacher: Executive Assistant & Operations, providing operational support to the team.
Startups interested in pitching to Qiming Venture Partners USA should visit their website at qimingvcusa.com. The firm prefers detailed decks that outline the business model, market opportunity, and team background. A warm introduction is beneficial but not mandatory. Response times can vary, but founders should expect feedback within a few weeks of submission.
In March 2023, Qiming Venture Partners USA announced the successful completion of its third fund, raising $550 million to continue its focus on early-stage healthcare investments. The firm has been actively involved in the healthcare sector since its founding in 2017, establishing a portfolio of over 30 companies.
Additionally, Qiming Venture Partners USA has recorded 11 mergers and acquisitions (M&A) and initial public offerings (IPOs), reflecting its commitment to fostering innovation in healthcare. The firm continues to explore new investment opportunities in the therapeutics and digital health sectors.
What are the investment criteria for Qiming Venture Partners USA?
The firm focuses on early-stage healthcare companies, particularly in therapeutics and digital health. They seek innovative solutions that can transform the healthcare landscape.
How can startups apply or pitch to Qiming Venture Partners USA?
Startups can pitch through the firm's website at qimingvcusa.com. They should include a detailed business plan and information about their team and product.
What makes Qiming Venture Partners USA different from other VC firms?
Qiming Venture Partners USA leverages its strong connections to the China market, providing portfolio companies with unique cross-border deal flow and market access.
What is the geographic scope of Qiming Venture Partners USA?
The firm primarily invests in North America and Europe, focusing on healthcare opportunities in these regions.
What is the typical check size for investments?
Qiming Venture Partners USA invests at various stages, including pre-seed, seed, seed-plus, and Series A, with check sizes varying based on the stage and specific opportunity.
What kind of post-investment involvement does Qiming Venture Partners USA have?
The firm provides operational support, access to its network, and resources to help portfolio companies grow and succeed in the competitive healthcare market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.